SeraSeal – world’s most advanced, next generation hemostatic technology, now in India
SeraSeal™
is an innovative primary haemostatic agent designed to stop bleeding on contact
and within seconds for arterial haemorrhages. It is comprised of agar and
bovine factor proteins II a VII a and IX a and X a and acts as a catalyst in
the clot formation process. This single-component system can tackle any
bleeding situation with the potential to save many lives. When seconds count,
SeraSeal™ can make the difference between life and death.
Ajaypal Singh Randhawa, Founder CEO, Swasth Kare
India is hopeful this will bring about a sea-change in the healthcare
landscape ‘By reducing blood loss, whole blood units needed, surgical time and
tissue conservation, every stage in healthcare will improve. Since saving lives
has always been at the forefront of Swasth Kare efforts, Seraseal in the hands
of the first responders or surgical theatres will be a huge step in this
direction” he commented.
The
first stage of trauma leads to haemorrhage and inflammation. Haemorrhages lead
to shock and resuscitation. And finally, all adverse events- haemorrhage;
inflammation; shock; and resuscitation on their own all lead to coagulopathy.
Coagulopathy
can lead to haemorrhage, only to continue the cycle of haemorrhage. Death is
the result if haemorrhage is not arrested. SeraSeal™, when used with other
surgical modalities, can effectively control bleeding in level III and level IV
type haemorrhages, in seconds, and can use in emergency and trauma cases.
Clinical studies and clinical use have demonstrated SeraSeal™’s unique
formulation to be effective in a wide range of coagulopathies. When SeraSeal™
is applied to a wound, it does not create inflammation or damage to the tissues
allowing the wound healing to occur sooner.
A
one-component haemostatic agent SeraSeal™ requires no mixing or preparation and
is available in multiple delivery systems to administer any wound to any part
of the body.By controlling bleeding, it reduces the substantial need for blood
transfusions, thereby, reducing risk and cost to the patient. In addition, cost
savings are realized through SeraSeal™ by reducing surgical time, wherein in
some cases, the savings are as much as 50% and shorter hospital stays.
“Seraseal
can save innumerable hours of clinical time, reduce post-op pain management and
help in tissue preservation. Patients, hospitals, medical professionals,
surgeons, governments, military set-ups all will substantially benefit from
this product which is lifesaving” added Randhawa.
“The
biggest contribution Swasth Kare
can possibly make is to assist the medical community with products that are
proven to save lives, increase surgical efficiency, and assist first responders
from the initial point of contact with an injured patient “
SeraSeal is the world's first primary
haemostatic agent that arrests bleeds within seconds! By reducing blood loss, whole blood units
needed, time in surgery and precious tissue, every stage of healthcare is
substantially impacted. If we truly
place the lives of patients at the forefront, we use SeraSeal to stop bleeding
whether in the hands of first responders or in the surgical theatre. We save countless thousands of hours of
clinical time, reduce post-op pain management and preserve tissue. Patients, medical professionals, insurance
companies, governments, military troops all benefit from this product which
saves both lives and costs. BW
Comments
Post a Comment